Farmland LP, Carbon Friendly Submit First U.S. Regenerative Farming Carbon Credits to Verra

Farmland LP, Carbon Friendly Submit First U.S. Regenerative Farming Carbon Credits to Verra

Farmland LP, the largest U.S. manager exclusively focused on organic and regenerative farmland, together with Carbon Friendly, a leading developer of regenerative carbon projects, have achieved a major milestone in the voluntary carbon market. The two organizations have submitted the…

Read MoreFarmland LP, Carbon Friendly Submit First U.S. Regenerative Farming Carbon Credits to Verra
Verily, UCHealth, CU Anschutz, and RefinedScience Unite for AI-Driven Research and Care

Verily, UCHealth, CU Anschutz, and RefinedScience Unite for AI-Driven Research and Care

Verily announced a multi-year strategic collaboration with UCHealth, the University of Colorado Anschutz Medical Campus, and RefinedScience aimed at transforming the use of biomedical data and redefining how patient care is delivered. This partnership leverages Verily’s expertise in healthcare technology…

Read MoreVerily, UCHealth, CU Anschutz, and RefinedScience Unite for AI-Driven Research and Care
Syncell Strengthens European Presence to Boost Disease Research and Drug Discovery

Syncell Strengthens European Presence to Boost Disease Research and Drug Discovery

Syncell Inc., a pioneering company in next-generation unbiased subcellular proteomics, has announced the deployment of its commercial Microscoop® Mint technology at two of Europe’s most prestigious research institutes renowned for proteomics and advanced technology adoption. The Max Planck Institute of…

Read MoreSyncell Strengthens European Presence to Boost Disease Research and Drug Discovery
Pilatus Biosciences Secures Global Patent for Novel CD36-Targeted Immunotherapy

Pilatus Biosciences Secures Global Patent for Novel CD36-Targeted Immunotherapy

Pilatus Biosciences Inc., a biopharmaceutical company pioneering metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, announced the issuance of its foundational patent in Europe and Australia titled “Methods for Modulating Regulatory T Cells and Inhibiting Tumor Growth.” This milestone marks…

Read MorePilatus Biosciences Secures Global Patent for Novel CD36-Targeted Immunotherapy